Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vuk Zdinjak

Evogene Co, 'When Biology Meets Disruptive Technologies,' Confirms Earnings Results Release Date

Computational biology company Evogene Ltd. (NASDAQ:EVGNwill release its financial results for the full year and fourth quarter of 2021 on March 10, 2022. On the day of the announcement, the company's management will host a conference call to discuss the results at 09:00 a.m. EST.

Evogene established three unique technological engines, MicroBoost AI, ChemPass AI and GeneRator AI. Each technological engine is focused on the discovery and development of products based on one of the following core components: microbes (Microboost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI). The company uses its technological engines to develop products through subsidiaries and with strategic partners. Evogene's main subsidiaries utilize the technological engines to develop novel products as follows: human microbiome-based therapeutics by Biomica Ltd., medical cannabis by Canonic Ltd., ag-chemicals by AgPlenus and ag-biologicals by Lavie Bio Ltd

Price Action

Evogene shares traded 1.63% higher at $1.25 per share at the time of writing Tuesday morning.

 
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.